TWEETS and retweets by @pharma_BI and @AVIVA1950 on Day One and Day Two: 2019 MassBio Annual Meeting, State of Possible Conference, Sonesta Hotel, Cambridge, March 27, 2019
Your Tweets earned 2,561 impressions over the last 24 hours
-
LIVE Day Two: 2019 MassBio Annual Meeting, State of Possible Conference, Sonesta Hotel, Cambridge, March 28, 2019 http://pharmaceuticalintelligence.com/2019/03/28/live-day-two-2019-massbio-annual-meeting-state-of-possible-conference-sonesta-hotel-cambridge-march-28-2019/ …
-
AMAZING Conference I covered in Real Time TODAY on Biotech Therapeutics Innovations in Massachusetts…
-
LIVE Day One: 2019 MassBio Annual Meeting, State of Possible Conference, Sonesta Hotel, Cambridge, March 27, 2019 http://pharmaceuticalintelligence.com/2019/03/27/live-day-one-2019-massbio-annual-meeting-state-of-possible-conference-sonesta-hotel-cambridge-march-27-2019/ …
-
Amazing desert at Farewell Party 2nd Day afternoon
#StateofPossible19 only one suggestion for 2020 App with All Attendees @Pharma_BI@AVIVA1950
-
-
You Retweeted
Massachusetts biopharma employment has grown 28% in last 10 years, to 69,000+ employees.
#StateofPossible19
-
You Retweeted
Congratulations to Lita Nelsen, Retired Director, MIT, Technology Licensing Office on receiving the Henri A. Termeer Innovative Leadership Award during the
@MassBio State of Possible Conference.#StateOfPossible19
-
You Retweeted
MIT Legend at MassBio’s “State of Possible” reception… Lita Nelsen will receive the Henri A. Termeer Innovation Award at Thursday MassBio conference.
-
You Retweeted
Great first day
@MassBio#StateofPossible19 Conference. Kicked off with compelling keynote by@jmaxlevin of Ovid therapeutics highlighting#healthcare trends#biotech and#pharma innovation,#oncology and#genomics breakthroughs, and#health integration#drug#pricing
-
You Retweeted
Day 2 at
@MassBio#StateOfPossible19 conference. Next talk – the future of human biology. Among speaker, Juan Enriquez, well known author “the future of life”.
-
You Retweeted
Congrats Lita Nelsen!! Our newest recipient of the Henri A. Termeer Innovative Leadership Award!! Thank you for making MA so amazing for innovation and patients!!!!
@MassBio@MIT#StateOfPossible19
-
You Retweeted
Congrats Lita Nelsen winner of Henri A. Termeer Innovative Leadership Award. She was part of the biotechnology revolution in Cambridge. Amazing woman.
@MassBio@MIT#StateofPossible19#BIOTECH@SanofiGenzyme#research
-
You Retweeted
-
You Retweeted
Lita Nelson is the 2019 Henri Termeer Innovative Leadership Award winner. She gave us a wonderful
#biotech history lesson.#StateOfPossible19@MassBio
-
You Retweeted
-
You Retweeted
-
You Retweeted
-
You Retweeted
Great information from
@MassBio#StateOfPossible19 .#CRISPR will be revolutionary and hreat that@US_FDA taking the reigns on#regulatory issues#biotech#fiercebiotech -
You Retweeted
Very important if
@NCIDataSci can come up with a universal#datastrategy on#openaccess platform@Pharma_BI@AVIVA1950
-
You Retweeted
Great discussion on
#biosimilars@MassBio#StateofPossible19 conference. See@Pharma_BI for live@Twitter coverage.@AVIVA1950 -
You Retweeted
-
You Retweeted
Researchers attribute woman’s
#pain-free life to a mutation in a previously unidentified#gene.@AVIVA1950@Pharma_BI@StephenJWillia2 -
You Retweeted
-
LIVE e-Proceedings of Day Two: 2019 MassBio Annual Meeting, State of Possible Conference, Sonesta Hotel, Cambridge, March 28, 2019
#StateofPossible19@AVIVA1950 https://pharmaceuticalintelligence.com/2019/03/28/live-day-two-2019-massbio-annual-meeting-state-of-possible-conference-sonesta-hotel-cambridge-march-28-2019/ … via@Pharma_BI -
My Hero, our out going President & CEO
@MassBio exemplary executive, you are unique and very special to MA and to Biotech in MA#StateofPossible19 @Pharma_BI@AVIVA1950
-
25 companies lunched every year out of
@MIT @litanelson headed@MIT#TechnologyTransfer gets Henri Termeer#Innovation#Leadership innovations from@MIT or Academe to start up stage, history on innovations@MIT#StateofPossibility19 @Pharma_BI@AVIVA1950
-
Great ideas for the small biotech difficult to invest in
#diagnostics unless a#companion is available drug more attractive vs diagnostics, biomarkers are attractive vs tests
-
Hot Investment are not Hemophilia new ventures said M&A Private was stripped by public markets grow into public market said
@LifeSciVC@CristineBrennan Oncology remains attractive#StateOfPossible19 @Pharma_BI@AVIVA1950
-
Coolest mind in the room packed with smart biotech execs and genomic experts, aka
@EvolvingJuan @MassBio#StateOfPossible19 @Pharma_BI@AVIVA1950 Cambridge, MA parking lots deals are made, Berklee best music@Boston cool place to be@GeorgeChurch in#lab
-
Opposing natural selection is Gene editing, gene repair may lead to life forms due to consequences unknown
@Pharma_BI@AVIVA1950#StateofPossible19
-
#StateofPossible19 @Pharma_BI@AVIVA1950#opioids#casualties in 2018 greater than#Road#accidents#death in the US@Boston#Police active in the#Addiction &#Recovery#initiatives
-
Like no other state in the US – Biotech has infrastructure in MA, amazing squared content & Organization Event Planning Score = 100/100
@Pharma_BI@AVIVA1950#StateofPossible19
-
Women were on all Panels today amazing squared content & Organization Event Planning Score = 100/100
@Pharma_BI@AVIVA1950#StateofPossible19
-
Jeremy Levin’s Speech was my favorite – I never agree 100% with any one — WIth Levin I do
@Pharma_BI@AVIVA1950#StateofPossible19 -
indeed, Jeremy Levin is BOLD, Visionary, An equal opportunity promoter, a Universal Health Care ideologue LIKE ME
@Pharma_BI@AVIVA1950 democratic values UPHOLDER LIKE ME@MassBio amazing squared content & Organization Event Planning Score = 100/100#StateofPossible19
-
amazing squared content & Organization Event Planning Score = 100/100
@Pharma_BI@AVIVA1950#StateofPossible19
-
amazing squared content & Organization Event Planning Score = 100/100
@Pharma_BI@AVIVA1950#StateofPossible19
-
You Retweeted
We need cross industry partnerships to address our transportation issues.
#MA#biotech#StateOfPossible19
-
You Retweeted
Hosting hot takes in a
#firesidechat re#CRISPR and#RNAI therapies with two genomic all-stars@JMaraganore of@Alnylam and@ksbosley formerly of@editasmed at@MassBio#StateofPossible19 Conference!
-
amazing squared content & Organization Event Planning Score = 100/100
@Pharma_BI@AVIVA1950#StateofPossible19 -
amazing squared content & Organization Event Planning Score = 100/100
@Pharma_BI@AVIVA1950#StateofPossible19
-
amazing squared content & Organization Event Planning Score = 100/100
@Pharma_BI@AVIVA1950#StateofPossible19 -
amazing squared content & Organization Event Planning Score = 100/100
@Pharma_BI@AVIVA1950#StateofPossible19
-
amazing squared content & Organization Event Planning Score = 100/100
@Pharma_BI@AVIVA1950#StateofPossible19 -
amazing squared content & Organization Event Planning Score = 100/100
@Pharma_BI@AVIVA1950#StateofPossible19
-
amazing squared content & Organization Event Planning Score = 100/100
@Pharma_BI@AVIVA1950#StateofPossible19
-
You Retweeted
Packed room here at the
@MassBio Conference! We are delighted to be here for the first ever State of Possible Award. Congrats to@BostonFire commissioner Joe Finn and thank you for all you do to prevent more fire fighter deaths from occupational cancer.#StateofPossible19
-
LIVE Day One e-Proceedings: 2019
@MassBio Annual Meeting, State of Possible Conference, Sonesta Hotel, Cambridge, March 27, 2019#StateofPossible19 https://pharmaceuticalintelligence.com/2019/03/27/live-day-one-2019-massbio-annual-meeting-state-of-possible-conference-sonesta-hotel-cambridge-march-27-2019/ … via@Pharma_BI@AVIVA1950 -
CEO developing blood test for cancer diagnosis ask Neurodegeneration Panel
@MASSBio a question asking them to finction as his advisory board for a question on using blood test got CNS disfunction diagnosis? Brilliant bold act#StateOfPossible19@Pharma_BI@AVIVA1950 was delight -
Panel of Geneticists, Neurologists, Psychiatrists TOP talent on CNS regeneration debates genetic mutation
@JosephHiggins lead the pack on neuropathology paradigm shift on which proteins are targeted therapeutics patient selection#StateofPossible19 @Pharma_BI@AVIVA1950
-
#StateofPossible19 @Pharma_BI@AVIVA1950 panel of experts on Neurodegeneration#Huntington progranulin ,#ALS#Alzheimers @TakedaPharma#GeneTherapy considered for CNS, targeting#proteins , @biogen#mechanisms@Serepta drug-CSF Distribution dose range
-
#StateofPossible19 @Pharma_BI@AVIVA1950#Life impact of#biotech , how to maintain Boston as Biotech HUB?#Innovations#partnership with @broadinstitute attract great talent @SanofiGenzyme culture is asset on the balance sheet#livability@MA PARKING
-
#StateofPossible19 @Pharma_BI@AVIVA1950 amazing Panel on funding biotech start ups Women CEO in Biotech, is tough. Raising funds requires relations women are great at relations, bias by gender exists
-
#StateofPossible19 @pharma_BI@AVIVA1950 Patient Advocate, Lauren Bombardier Weeks took stage describing Cystic Fibrosis breakthrough story
-
#StateofPossible19 @Pharma_BI@AVIVA1950 Mike Bonney @KaleidoLifesciences#value-based constructs of#therapeutics:#population impact when#patients start a given#therapy – research shows that change in x yield favorable outcomes thus, approval#drug coverage by#Payer -
#StateofPossible19 @Pharma_BI@AVIVA1950 #Value to Fix#HealthcareSystem#Access Margaux Hall@ErinMistry@SyneosHealth Tamar Thompson@bmsnews Mike Bonney @KaleidoBiosciences#Payors want#patients to pay out-of-pocket conflict of interest#risk for#drug#manufactors -
#StateofPossible19 @Pharma_BI@AVIVA1950 @Alnylam#CEO @editasmed#CEO @BEAM#Base#editing as a#Human#Therapy#genetic#disease faulty#geneexpression#Genecorrection#Generegulation#Genesilencing#GenereprogrammingTreating#geneticdisease ONE LETTER AT A TIME -
#StateofPossible19 @Pharma_BI@AVIVA1950 @Alnylam#CEO @editasmed#CEO Future: In five years there will be 5 new products based on RNA, pass ceiling of 1st approval same technology for solutions of multiple disease indication -
#StateofPossible19 @Pharma_BI@AVIVA1950 @Alnylam former#CEO @editasmed#CEO @KatrineBosley#regulators need to move faster as they see the#innovations for#tissue by#gene#medicine Dialog with@FDA will continue#Human#germ#line is NOT appropriate -
#StateofPossible19 @Pharma_BI@AVIVA1950 @Alnylam#CEO @editasmed#CEO on approval of#RNA#drug and#gene#tidsue#editing#technology for#therapies not known before
-
#StateofPossible19@Pharma_BI@AVIVA1950@, Chairman & CEO, @OvidTherapeutics, Inc.#capital is flowing in LARGE amounts into#innovations 2500#clinicaltrials in#immuneoncology – product emerging as#biosimilars#celltherapy,#genetherapy#health#insurers pay/not
Your Tweets earned 2,561 impressions over the last 24 hours
Top Tweets by number of Impressions
-
ImpressionsEngagementsEngagement rate
-
Aviva Lev-Ari @AVIVA1950 Mar 27#StateofPossible19 @Pharma_BI @AVIVA1950 @Alnylam #CEO @editasmed #CEO @BEAM #Base #editing as a #Human #Therapy #genetic #disease faulty #geneexpression #Genecorrection #Generegulation #Genesilencing #GenereprogrammingTreating #geneticdisease ONE LETTER AT A TIME54610.2%View Tweet activity -
Promote
-
Aviva Lev-Ari @AVIVA1950 Mar 28Coolest mind in the room packed with smart biotech execs and genomic experts, aka @EvolvingJuan @MassBio #StateOfPossible19 @Pharma_BI @AVIVA1950 Cambridge, MA parking lots deals are made, Berklee best music @Boston cool place to be @GeorgeChurch in #lab pic.twitter.com/uL46hdUM0a37110.3%View Tweet activity
-
Promote
-
Aviva Lev-Ari @AVIVA1950 Mar 2@TechnionT3 #scientific #engineering #medical #innovation #research @Israel @Global #progress @Boston @pharma_BI @AVIVA1950 #eJournal #eBooks #Medicine #Biotech #Conference #eProceedings 1.6M #Global #eReaders 2M #Followers explore #joint #venture #IP pic.twitter.com/hRhuvc7EU036510.3%View Tweet activity
-
Promote
-
Aviva Lev-Ari @AVIVA1950 Mar 28#StateofPossible19 @Pharma_BI @AVIVA1950 #opioids #casualties in 2018 greater than #Road #accidents #death in the US @Boston #Police active in the #Addiction & #Recovery #initiatives pic.twitter.com/cd4ewAAXCJ29241.4%View Tweet activity
-
Promote
-
Aviva Lev-Ari @AVIVA1950 Mar 28Great ideas for the small biotech difficult to invest in #diagnostics unless a #companion is available drug more attractive vs diagnostics, biomarkers are attractive vs tests pic.twitter.com/7IM6YXe2i727810.4%View Tweet activity
-
Promote
-
Aviva Lev-Ari @AVIVA1950 Mar 27#StateofPossible19 @Pharma_BI @AVIVA1950 @Alnylam former #CEO @editasmed #CEO @KatrineBosley #regulators need to move faster as they see the #innovations for #tissue by #gene #medicine Dialog with @FDA will continue #Human #germ #line is NOT appropriate244124.9%View Tweet activity
-
Promote
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aptubman
Arav Gandhi
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
ritusaxena
Rick Mandahl
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
zraviv06
zs22
Leave a Reply